Spyre Therapeutics, Inc SYRE 深 沪
等待开盘 07-01 09:30:00 美东时间
88.78
-1.380
-1.53%
华盛通- 最 高91.955
- 今 开90.30
- 成交量 145.16万股
- 最 低 88.60
- 昨 收 90.16
- 总市值 77.10亿
- 52周最高 102.06
- 市盈率 静 --
- 换手率 1.67%
- 52周最低 14.505
- 委 比 94.11%
- 总股本 8684.13万
- 历史最高 318.75
- 量 比 0.48
- 振 幅 3.72%
- 历史最低 2.66
- 每 手 1
- 风险率 22.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Going On With Spyre Therapeutics Stock On Wednesday?
Spyre Therapeutics Inc. (NASDAQ:SYRE) stock plunged more than 12% on Wednesday as investors reacted to large insider stock sales. The stock is up more than 160% year to date and over 450% over the past year. Insider Sales Weigh on Sentiment Fairmount Healthcare Fund II L.P., affiliated with company ...
06-24 23:56
美股大行评级 | 美银上调美光科技目标价从950美元升至1500美元，上调迈威尔科技目标价从240美元升至365美元
今日重点评级关注：摩根士丹利：维持杜邦"标配"评级，目标价从52美元升至156美元；蒙特利尔银行：维持Taysha Gene Therapies"跑赢大市"评级，目标价从10美元升至14美元
06-24 14:08
Deutsche Bank Maintains Buy on Spyre Therapeutics, Raises Price Target to $135
Deutsche Bank analyst David Hoang maintains Spyre Therapeutics (NASDAQ:SYRE) with a Buy and raises the price target from $115 to $135.
06-23 21:37
Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket
Shares of SAGTEC GLOBAL Ltd (NASDAQ:SAGT) gained 75.6% to $1.74 in pre-market trading after the Kuala Lumpur-based enterprise software firm issued financial year 2026 guidance projecting 35% revenue growth. Sagtec projected $25.78 million in revenue, up from $19.1 million in the financial year 2025....
06-22 17:21
